Clinical trial · Interventional
Bitter Taste Receptors in Oropharynx Cancer
Expression of Bitter Taste Receptors in Oropharynx Carcinoma
NCT05211427CI-TRIAL-00064704unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this work is to investigate the expression of the bitter taste receptors in p16-positive and negative oropharyngeal carcinomas (in comparison to healthy, local tissue).
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Oropharynx Cancer | Malignant Oropharyngeal Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Biopsy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Patients
- description
- Patients with oropharynx cancer
- interventionNames
- Procedure: Biopsy
- type
- EXPERIMENTAL
- label
- Healthy subjects
- description
- Patients with non malignant pharynx pathology
- interventionNames
- Procedure: Biopsy
Primary outcomes (1)
- measure
- Expression of TAS2-Receptors
- timeFrame
- The day of surgery and the day before
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Oropharynx SCC for the patient group * signed informed consent for all Exclusion Criteria: \-
References
Publications (0)
Data not yet available
No reference posted for this study.